These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
53 related articles for article (PubMed ID: 1835748)
1. [Response to hepatitis B vaccine in patients with alcoholic liver disease]. Domínguez F; Delgado E; Carrandi B; Rada MC Med Clin (Barc); 1991 Sep; 97(9):353. PubMed ID: 1835748 [No Abstract] [Full Text] [Related]
2. Hepatitis B vaccine joins the fight against pandemic disease. Clements CJ; Kane M; Hu DJ; Kim-Farley R World Health Forum; 1990; 11(2):165-8. PubMed ID: 2148676 [No Abstract] [Full Text] [Related]
3. [Control of the effectiveness of a vaccine campaign against hepatitis B among the health personnel]. de las Cuevas Saa MB; Galán Sánchez F; Rodríguez-Iglesias MA; Ares Camerino A Rev Clin Esp; 1992 Apr; 190(7):382. PubMed ID: 1535718 [No Abstract] [Full Text] [Related]
4. Immunogenicity and safety of recombinant yeast-derived hepatitis B vaccine in haemodialysis patients. Fujiyama S; Yoshida K; Sato T; Shimada H; Deguchi T Hepatogastroenterology; 1990 Dec; 37 Suppl 2():140-4. PubMed ID: 2150664 [TBL] [Abstract][Full Text] [Related]
5. Immunogenicity, reactogenicity and comparison of two doses of recombinant DNA yeast-derived hepatitis B vaccine in Ethiopian children. Tsega E; Tafesse B; Horton J; Nordenfelt E; Wolde-Hawariat G; Hansson BG; Lindberg J Trop Geogr Med; 1991; 43(1-2):220-7. PubMed ID: 1836290 [TBL] [Abstract][Full Text] [Related]
6. Intradermal hepatitis B vaccine. Lunn JA Lancet; 1989 Mar; 1(8638):625. PubMed ID: 2564156 [No Abstract] [Full Text] [Related]
7. Hepatitis B vaccines. N Z Med J; 1988 Dec; 101(859):831. PubMed ID: 2974517 [No Abstract] [Full Text] [Related]
12. Antibody responses to intradermal recombinant hepatitis B immunization among HIV-positive subjects. Ristola MA; Vuola JM; Valle M; von Reyn CF Vaccine; 2004 Nov; 23(2):205-9. PubMed ID: 15531038 [TBL] [Abstract][Full Text] [Related]
13. [Hepatitis B virus vaccination in the province of Saragossa]. Arribas Monzón FE; Abad Díez JM; Amorín Calzada MJ; Barrasa Villar I; Aibar Remón C; García Mata JR; Gómez López LI Enferm Infecc Microbiol Clin; 1990 Dec; 8(10):629-34. PubMed ID: 2151507 [TBL] [Abstract][Full Text] [Related]
14. Intramuscular versus low-dose intradermal hepatitis B vaccine. Assessment by humoral and cellular immune response to hepatitis B surface antigen. Frazer IH; Jones B; Dimitrakakis M; Mackay IR Med J Aust; 1987 Mar; 146(5):242-5. PubMed ID: 2950303 [TBL] [Abstract][Full Text] [Related]
16. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates. Gunn TR; Bosley A; Woodfield DG N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527 [TBL] [Abstract][Full Text] [Related]
17. Suboptimal response to hepatitis B vaccine given by injection into the buttock. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1985 Mar; 34(8):105-8, 113. PubMed ID: 3155822 [No Abstract] [Full Text] [Related]
18. [Results of an anti-hepatitis-B vaccination in a population at risk]. Stellato M; Carbi S; Tosolini S Boll Ist Sieroter Milan; 1989; 68(1):34-41. PubMed ID: 2535244 [TBL] [Abstract][Full Text] [Related]
19. [Immune response to hepatitis B vaccine produced with genetic engineering]. Ramón Torrell JM; Micheo Salas C; Cerdó Goicouria C; Casas García I; Escribá Jordana JM Rev Clin Esp; 1991 Feb; 188(2):68-71. PubMed ID: 2041902 [TBL] [Abstract][Full Text] [Related]
20. Antibody responses to recombinant, yeast-derived hepatitis B vaccine in teenage New Zealand children. Milne A; Moyes CD; Allwood GK; Pearce NE; Krugman S N Z Med J; 1988 Feb; 101(840):67-9. PubMed ID: 2967940 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]